Literature DB >> 19359344

Cardiac infiltration in early-onset sarcoidosis associated with a novel heterozygous mutation, G481D, in CARD15.

Satoshi Okada, Nakao Konishi, Miyuki Tsumura, Kenichiro Shirao, Shin'ichiro Yasunaga, Hidemasa Sakai, Ryuta Nishikomori, Yoshihiro Takihara, Masao Kobayashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19359344     DOI： 10.1093/rheumatology/kep061

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  6 in total

Review 1.  NOD1 and NOD2 in inflammatory and infectious diseases.

Authors:  Bruno C Trindade; Grace Y Chen
Journal:  Immunol Rev       Date:  2020-07-17       Impact factor: 12.988

Review 2.  Early diagnosis of early-onset sarcoidosis: a case report with functional analysis and review of the literature.

Authors:  Yusuke Takeuchi; Tomonari Shigemura; Norimoto Kobayashi; Naoe Kaneko; Tomoyuki Iwasaki; Kisei Minami; Keiko Kobayashi; Junya Masumoto; Kazunaga Agematsu
Journal:  Clin Rheumatol       Date:  2017-01-27       Impact factor: 3.650

Review 3.  Blau syndrome, the prototypic auto-inflammatory granulomatous disease.

Authors:  Carine H Wouters; Anne Maes; Kevin P Foley; John Bertin; Carlos D Rose
Journal:  Pediatr Rheumatol Online J       Date:  2014-08-06       Impact factor: 3.054

4.  A familial case of Blau syndrome caused by a novel NOD2 genetic mutation.

Authors:  Woojoong Kim; Eujin Park; Yo Han Ahn; Jiwon M Lee; Hee Gyung Kang; Byung Joo Kim; Il-Soo Ha; Hae Il Cheong
Journal:  Korean J Pediatr       Date:  2016-11-30

Review 5.  Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease.

Authors:  Francesco Caso; Paola Galozzi; Luisa Costa; Paolo Sfriso; Luca Cantarini; Leonardo Punzi
Journal:  RMD Open       Date:  2015-07-20

6.  Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators.

Authors:  Rhiannon Parkhouse; Joseph P Boyle; Tom P Monie
Journal:  FEBS Lett       Date:  2014-08-02       Impact factor: 4.124
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.